A randomized controlled study on the analgesic treatment of migraine in acute phase with the combination of horizontal penetration needling and rizatrita

Not Applicable

• Conditions: migraine

• Registration Number: ITMCTR2024000156
• Lead Sponsor: anjing Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Meet the diagnostic criteria of migraine without aura and migraine with aura;

2) Aged 18-50 years, with a history of migraine for more than 12 months;

3) In the acute phase, the pain degree was evaluated by visual analogue scale (VAS) method with 4 points or more;

4) Patients voluntarily received relevant acute analgesia treatment and signed informed consent.

Exclusion Criteria

1) Patients with hypertension and current unstable blood pressure control (stage 2, high-risk patients and above), coronary heart disease (including patients with pacemakers), cerebral infarction and other cardiovascular and cerebrovascular stenosis or obstructive diseases, peripheral vascular stenosis and obstruction;
2) Patients with severe primary diseases such as liver, kidney, digestion and blood system;
3) Mental patients, or patients with infection and bleeding;
4) Pregnant or lactating women;
5) Patients with organic lesions;
6) Patients who cannot understand and cooperate with the visual analogue scale (VAS) method.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified